US secures over 750,000 doses of GSK-Vir COVID-19 drug
November 17, 2021Research and Development
The US has secured GSK and Vir Biotechnology’s antibody-based COVID-19 treatment, through signing contracts worth approximately $1 billion, according to …
Orexo’s new drug effective against opioid overdoses
November 16, 2021Manufacturing and Production
Orexo announced it has successfully completed the trial for its lead pharmaceutical pipeline asset, OX124, designed to help patients in …
Moderna announce promising study in mRNA drug for heart failure
November 16, 2021Manufacturing and Production
The biotechnology company Moderna have announced positive data from the AstraZeneca-led Phase IIa EPICCURE trial, evaluating the use of a …
Revelar Biotherapeutics launches for development of COVID-19 and other antibody therapeutics
November 16, 2021Manufacturing and Production
Twist Bioscience Corporation announced that it has launched Revelar Biotherapeutics, an independently operated, new biotechnology company to develop and commercialise …
Arrowhead Collaboration presents Phase IIb data from Hepatitis B study
November 16, 2021Manufacturing and Production
Arrowhead Pharmaceuticals Inc collaborator, Janssen Pharmaceuticals Inc, have presented clinical data from REEF-1, a Phase IIb study of different combination …
Emergex trial new form of COVID vaccine
November 15, 2021Sales and Marketing
Emergex, an Oxfordshire based company, is moving towards Phase I trials for its novel COVID-19 vaccine, which is applied as …
Theramex launches Femarelle to treat menopause symptoms
November 15, 2021Sales and Marketing
Theramex recently announced that they have acquired the Femarelle ® product licence to treat menopause symptoms. The commercialisation agreement was reached …
Pfizer vaccine generates most antibodies, comparative study suggests
November 15, 2021Sales and Marketing
Pfizer Inc. and BioNTech’s COVID-19 vaccine yielded the strongest immune response in a comparative study of four vaccines. The study, …
First patient dosed in tumour membrane immunotherapy trial
November 15, 2021Sales and Marketing
Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumour membrane immunotherapy, announced that …
Biogen’s Aduhelm shown to reduce clinical decline in Alzheimer’s disease
November 12, 2021Medical Communications
New ADUHELM (aducanumab-avwa) Phase III data has shown a positive correlation between plasma p-tau reduction and less cognitive and functional …
Blood pressure drugs could protect against type 2 diabetes
November 12, 2021Medical Communications
Researchers have found that blood pressure drugs may directly reduce people’s risk of type 2 diabetes, a condition that an …
Trial investigates whether immunosuppressant holiday boosts vaccine protection
November 12, 2021Medical Communications
A trial has been launched to evaluate how to increase COVID-19 vaccine protection among vulnerable patients taking immunosuppressant drugs . …
Kintor Pharma begins Phase II trial of KX-826 for androgenetic alopecia treatment
November 12, 2021Medical Communications
Kintor Pharma, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the company has dosed the …
New experimental drug identified for pancreatic cancer treatment
November 11, 2021Business Services
Professor Shudong Wang, Head of Drug Discovery and Development at the University of South Australia, is hoping to utilise the …
NICE recommends mogamulizumab for treatment of ultra-rare blood cancers
November 11, 2021Business Services
NICE has recommended POTELIGEO (mogamulizumab), manufactured by Kyowa Kirin, as a treatment option for adults in England in Wales with …
Study shows cancer treatments could be repurposed as Alzheimer’s drugs
November 11, 2021Business Services
A new study published in Science Advances has shared that cancer drugs can be repurposed as therapies to be tested …
New study confirms role of digital biomarkers in monitoring patients with multiple sclerosis
November 11, 2021Business Services
Results from a clinical study, published by Ad Scientiam in ‘Multiple Sclerosis and Related Disorders, secure the place of MSCopilot ® for the …
Pfizer ask FDA to authorise COVID booster in adults
November 10, 2021Research and Development
Pfizer have requested that the FDA authorise booster shots of the COVID-19 vaccine in all Americans 18 and older, citing …
COMPASS Pathways announce positive results in clinical trial for treatment-resistant depression
November 10, 2021Research and Development
COMPASS Pathways, a mental health care company dedicated to the acceleration of patient access to evidence-based innovation in mental health, …
Pleco Therapeutics partners with Hyloris to develop novel cancer agent
November 10, 2021Research and Development
Specialty biopharma company, Pleco Therapeutics, have announced the beginning of a strategic collaboration with Hyloris Pharmaceuticals, to develop and commercialise …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
